Marc Cohen

Track

Insider profile

Currently holds positions in Korro Bio, Inc. and C4 Therapeutics, Inc.

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Korro Bio, Inc. None -
Founder, Executive Chairman C4 Therapeutics, Inc. None -
Marc Cohen's trades of C4 Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
55.29
Quantity 16,538 +42.0%
Value US$280,178
Transaction date
Purchase
Price
153.73
Quantity 20,527 +42.3%
Value US$3,222,775
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-10-06 2020-10-06
B Purchase
16,538 +42.0%
55.29
US$280,178 		16,538 +42.0% 55.29 US$280,178
2019-10-08 2019-10-07
B Purchase
20,527 +42.3%
153.73
US$3,222,775 		20,527 +42.3% 153.73 US$3,222,775
2004-05-05 2004-05-04
PlS Planned sale
98,425 +23.0%
144.52
US$4,506,974 		98,425 +23.0% 144.52 US$4,506,974
2004-05-05 2004-05-03
PlS Planned sale
2,500 -0.1%
14.87
US$37,174 		2,500 -0.1% 14.87 US$37,174